139 related articles for article (PubMed ID: 140543)
1. [Partial synchronization of tumor cells in vivo with hydroxyurea (author's transl)].
Hartenstein R; Pfundmair K; Possinger K
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1977; 88(3):261-72. PubMed ID: 140543
[TBL] [Abstract][Full Text] [Related]
2. [In vivo cell cycle synchronization of the murine sarcoma 180 by continuous colcemid infusion (author's transl)].
Nomura T
Nihon Seikeigeka Gakkai Zasshi; 1980 Dec; 54(12):1719-32. PubMed ID: 7288228
[TBL] [Abstract][Full Text] [Related]
3. [Failure to partial synchronization with hydroxyurea to improve results of chemotherapy of solid neurosarcoma in the rat (author's transl)].
Volm M; Wayss K
Dtsch Med Wochenschr; 1975 Oct; 100(41):2102-4. PubMed ID: 1164881
[TBL] [Abstract][Full Text] [Related]
4. Synchronization of hepatocellular DNA synthesis in regenerating rat liver by continuous infusion of hydroxyurea.
Rabes HM; Iseler G; Czichos S; Tuczek HV
Cancer Res; 1977 Apr; 37(4):1105-11. PubMed ID: 844040
[TBL] [Abstract][Full Text] [Related]
5. Studies of hydroxyurea administered by continuous infusion: toxicity, pharmacokinetics, and cell synchronization.
Belt RJ; Haas CD; Kennedy J; Taylor S
Cancer; 1980 Aug; 46(3):455-62. PubMed ID: 7397621
[TBL] [Abstract][Full Text] [Related]
6. [Study about the growth of two tumors of the solid Yoshida sarcoma of the rat in the same animals as well as about the reactions of tumors of different sizes to treatment with 2-, 3-, 5-trisethyleneiminobenzochinone (1,4) (author's transl)].
Hartleib J
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1974 Mar; 81(1):1-6. PubMed ID: 4275054
[No Abstract] [Full Text] [Related]
7. The cytotoxic effect of plasmin on Yoshida sarcoma cells.
Hilgard P; Hiemeyer V
Rev Fr Etud Clin Biol; 1969 Nov; 14(9):902-4. PubMed ID: 4243799
[No Abstract] [Full Text] [Related]
8. In vivo synchronization of murine sarcoma 37 ascites tumor cells by use of hydroxyurea.
Matthews RH; Dewar D; Webb TE
Physiol Chem Phys; 1976; 8(2):151-5. PubMed ID: 790422
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy in solid transplantation tumors following synchronization (author's transl)].
Volm M; Krieg L; Mattern J; Wayss K
Strahlentherapie; 1979 Feb; 155(2):137-44. PubMed ID: 425128
[TBL] [Abstract][Full Text] [Related]
10. [Synchronization of cellular proliferation in mice with sarcoma 37 by using hydroxyurea].
Demskiĭ VI
Biull Eksp Biol Med; 1976; 82(11):1352-4. PubMed ID: 1016718
[TBL] [Abstract][Full Text] [Related]
11. Critical survey of experimental data on in vivo synchronization by hydroxyurea.
Tubiana M; Frindel E; Vassort F
Recent Results Cancer Res; 1975; (52):187-205. PubMed ID: 1235000
[No Abstract] [Full Text] [Related]
12. [Studies on the stability of antitumor protein, neocarzinostatin. II. Stability of injection of neocarzinostatin (author's transl)].
Kono M; Ishii F; Haneda I; Koyama Y; Kikuchi M
Jpn J Antibiot; 1974 Dec; 27(6):715-24. PubMed ID: 4282495
[No Abstract] [Full Text] [Related]
13. Effects of double and multiple doses of hydroxyurea on mouse duodenum and mammary tumors.
Dethlefsen LA; Sorensen SP; Riley RM
Cancer Res; 1975 Mar; 35(3):694-9. PubMed ID: 1116130
[TBL] [Abstract][Full Text] [Related]
14. [Influence of hydroxyurea on DNA synthesis of human bone marrow in vivo (author's transl)].
Hartenstein R; Ertl E; Possinger K; Ehrhart H
Klin Wochenschr; 1979 Nov; 57(21):1191-3. PubMed ID: 513612
[TBL] [Abstract][Full Text] [Related]
15. [Irradiation of solid Walker carcino-sarcomas after synchronisation with hydroxyurea (author's transl)].
Wayss K; Mattern J; Volm M
Strahlentherapie; 1980 Jan; 156(1):41-5. PubMed ID: 6986673
[TBL] [Abstract][Full Text] [Related]
16. Effects of the plasma concentration of 5-fluorouracil and the duration of continuous venous infusion of 5-fluorouracil with an inhibitor of 5-fluorouracil degradation on Yoshida sarcomas in rats.
Fujii S; Shimamoto Y; Ohshimo H; Imaoka T; Motoyama M; Fukushima M; Shirasaka T
Jpn J Cancer Res; 1989 Feb; 80(2):167-72. PubMed ID: 2498251
[TBL] [Abstract][Full Text] [Related]
17. Anticancer activity and toxicity of S-1, an oral combination of tegafur and two biochemical modulators, compared with continuous i.v. infusion of 5-fluorouracil.
Fukushima M; Shimamoto Y; Kato T; Uchida J; Yonekura R; Ohshimo H; Shirasaka T
Anticancer Drugs; 1998 Oct; 9(9):817-23. PubMed ID: 9840729
[TBL] [Abstract][Full Text] [Related]
18. Schedule dependence of vincristine lethality in Sarcoma 180 cells following partial synchronization with hydroxyurea.
Mujagic H; Conger BM; Smith CA; Occhipinti SJ; Schuette WH; Shackney SE
Cancer Res; 1983 Aug; 43(8):3598-603. PubMed ID: 6861132
[TBL] [Abstract][Full Text] [Related]
19. Cytokinetic analysis of L1210 leukemia after continuous infusion of hydroxyurea in vivo.
Moran RE; Straus MJ
Cancer Res; 1979 May; 39(5):1616-22. PubMed ID: 427801
[No Abstract] [Full Text] [Related]
20. [Influence of resactin "Dessau" on the survival time of animals bearing nonspecific transplantation tumors (author's transl)].
Heber J; Hänsel H
Arch Geschwulstforsch; 1974; 44(1):47-54. PubMed ID: 4447440
[No Abstract] [Full Text] [Related]
[Next] [New Search]
